Alcohol Consumption Clinical Trial
Official title:
Vivitrol for Reducing Driving While Impaired Behavior Among Repeat Offenders-a Pilot Study
The purpose of this study is to determine whether Vivitrol is effective at reducing attempts to drive after drinking among repeat driving while intoxicated (DWI) offenders with Ignition Interlock devices.
Status | Completed |
Enrollment | 14 |
Est. completion date | May 2009 |
Est. primary completion date | May 2009 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria - Age = 18 - Capable of understanding and complying with the protocol, and has signed the informed consent document - Been convicted of a DWI offense, have at least one additional arrest for DWI, and be entering an ignition interlock program - They must be able to participate in a 6 month outpatient study; and reside within a one-hour commute to the research site - Women of childbearing potential must have a negative pregnancy test, use contraceptive methods, and not be breastfeeding - Negative urine toxicological screen for opiates at screening and randomization - Has a non-custodial stable residence and telephone Exclusion Criteria - Is pregnant and/or currently breastfeeding - Has a clinically significant medical condition or observed abnormality that is contraindicated for Vivitrol treatment - Is taking an excluded medication, including but not limited to benzodiazepines, anticonvulsants, opiates, or alcohol treatment medication - Not stable on current anti-depressant, as evidenced by less than 3 months at current dosage, plans to discontinue, or plans to change the dosage - Has been hospitalized for medical detoxification within 30 days of screening - Has evidence of severe kidney, heart, or lung disease - Has evidence of severe hepatic disease (as evidence by BUN > 10% above ULN, AST, ALT > 3x ULN, and GGT > 5x ULN at randomization) - Known or suspected hypersensitivity to naltrexone and/or Vivitrol in particular - Current diagnosis and symptoms of major depression, anxiety disorder, mania or psychosis (subjects with their illness in remission for 3 months may be included) - Opioid use within the past 14 days and/or current or recent (within the past year) diagnosis of dependence or abuse of opiates, benzodiazepines, or cocaine. - Current or anticipated need for prescribed opiate medication during the study period - Medication with naltrexone, disulfiram, acamprosate or other medication used to treat alcoholism within the past 30 days - Impending incarceration or other known situation that would preclude participation in the study - Other non-alcohol Axis I substance dependence diagnosis in the past 12 months, excluding nicotine, marijuana, and caffeine - Has participated in a clinical trial of a pharmacological agent within 30 days of screening - Has any finding that in the view of the principal investigator would compromise the subject's ability to fulfill the protocol visit schedule, and/or visit requirements or would affect subject safety during participation |
Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
Country | Name | City | State |
---|---|---|---|
United States | Behavioral Health Research Center of the Southwest | Albuquerque | New Mexico |
Lead Sponsor | Collaborator |
---|---|
Pacific Institute for Research and Evaluation | Cephalon |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Evidence of Attempts to Drive After Drinking | This was measured as Percent of days with an Interlock report of "Failure to Start" due to alcohol pre/on medication and 6 months post medication. | 6 months | No |
Primary | % Days w/1+Interlock Test Failures | This describes the percent of days in past month where the subject at least 1 interlock test failure. | One month post treatment | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05037630 -
Feasibility Evaluation of a Self-guided Digital Tool for Problematic Alcohol Use
|
N/A | |
Completed |
NCT03037749 -
Over-arousal as a Mechanism Between Alcohol and Intimate Partner Violence
|
N/A | |
Enrolling by invitation |
NCT02927132 -
Guilt and Expressive Writing for Reducing Alcohol Use in College Students
|
N/A | |
Completed |
NCT02905123 -
Brief Internet Intervention for Hazardous Alcohol Use
|
N/A | |
Enrolling by invitation |
NCT02952495 -
Online Education to Inform the Elderly About Age-related Alcohol Risks
|
Phase 2 | |
Completed |
NCT01923246 -
Development of IVR and WEB Alcohol Interventions
|
N/A | |
Completed |
NCT01129804 -
Network Support for Alcohol Treatment 2
|
N/A | |
Completed |
NCT00374153 -
Southern Methodist Alcohol Research Trial (SMART)
|
N/A | |
Completed |
NCT01126164 -
Parent Intervention to Reduce Binge Drinking
|
N/A | |
Completed |
NCT00383838 -
Self-Selected Brief Alcohol Intervention for Adolescents
|
N/A | |
Completed |
NCT03408743 -
Engineering an Online STI Prevention Program: CSE2
|
N/A | |
Recruiting |
NCT04957628 -
AlcoTail - Implementation of Tailored Interventions
|
||
Recruiting |
NCT04164940 -
Patient Trajectories for Older Adults Admitted to Hospital for Alcohol-related Problems
|
||
Completed |
NCT00292240 -
Brief Youth Substance Use Intervention for Primary Care
|
N/A | |
Completed |
NCT04804579 -
Boston ARCH 4F Intervention to Reduce Fall Risk in People With HIV and Alcohol Use
|
N/A | |
Completed |
NCT02387489 -
A Clinical Trial of SBIRT Services in School-based Health Centers
|
N/A | |
Completed |
NCT02188446 -
Intensive Smoking and Alcohol Cessation Intervention in Bladder Cancer Surgery Patients
|
N/A | |
Completed |
NCT01688245 -
A Text Message Behavioral Intervention to Reduce Alcohol Consumption in Young Adults
|
N/A | |
Withdrawn |
NCT01739842 -
Kudzu Effects on Brain Ethanol Levels: Proton Spectroscopy Assessment
|
Phase 2/Phase 3 | |
Completed |
NCT00561587 -
Quetiapine vs. Placebo in Alcohol Relapse Prevention - a Pilot Study
|
Phase 2 |